logo

For the Inventor, By the Inventor

Cincinnati, OH, United States of America

Winton D Jones

This inventor holds 35 USPTO granted patents, plus 7 CIPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Merrell Dow Pharmaceuticals, Richardson-Merrell Inc., Hoechst Marion Roussel. Active years: 1976-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Winton D Jones. Retrieved from https://idiyas.com/inventor/winton-d-jones

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 35

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.8

ph-index = 6

Forward Citations = 160(Granted Patents)


Company Filing History:

goldMedal28 out of 455 
 
Merrell Dow Pharmaceuticals
 patents
silverMedal6 out of 167 
 
Richardson-Merrell Inc.
 patents
bronzeMedal1 out of 236 
 
Hoechst Marion Roussel
 patents

Years Active: 1976-1999

Loading Chart...
Loading Chart...
Areas of Expertise:
Protein Kinase C
Cardiac Failure
Multi-Drug Resistance
Quinolyl Derivatives
Pyridinones
Antisecretory Agents
Oxazolones
Thiadiazines
Muscle-Relaxants
Glycoprotein Virus
Alkoxyimino Derivatives
Triazole-3-Thiols
35 patents (USPTO):Explore Patents
1. 6004959 - Alkyloxyamino substituted fluorenones and their use as protein kinase-C (1999-12-21),
2. 5428045 - 5-acyl-2-(1H)-pyridinoes (1995-06-27),
3. 5212315 - Alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones (1993-05-18),
4. 5212314 - Alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones (1993-05-18),
5. 5190957 - Treatment of multi-drug resistant tumors with quinolyl-and (1993-03-02),
6. 5182293 - Treatment of multi-drug resistant tumors with pyridyloxazole-2-ones (1993-01-26),
7. 5118696 - 5-Acyl-2-(1H)-pyridinones useful for treating cardiac failure (1992-06-02),
8. 5063238 - Prevention of glycoprotein enveloped virus infectivity by (1991-11-05),
9. 5061715 - Prevention of glycoprotein enveloped virus infectivity by quinolyl- and (1991-10-29),
10. 5043449 - Certain alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones (1991-08-27),
11. 4999431 - Process for preparing quinoline aldehyde and ketone derivatives (1991-03-12),
12. 4992452 - Certain 5-acyl-2-(1H)-pyridinones useful in treating cardiac failure (1991-02-12),
13. 4990519 - Method of using quinolyloxazole-2-ones as proteinkinase C inhibitors (1991-02-05),
14. 4920229 - Novel alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones (1990-04-24),
15. 4886811 - Qunolyloxazole-2-ones useful as proteinkinase C inhibitors (1989-12-12),

As an AI assistant specialized in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can provide you with the requested article about inventor Winton D Jones.

Title: The Innovations and Patents of Winton D Jones

Introduction:

Winton D Jones, a prolific inventor based in Cincinnati, OH (US), has left a significant mark in the field of pharmaceuticals with a remarkable portfolio of 35 patents. His inventive spirit and dedication to advancing medical science have led to groundbreaking discoveries that have the potential to revolutionize treatment methods for various diseases.

Latest Patents:

In his latest patents, Winton D Jones introduced two groundbreaking innovations:

1. Alkyloxyamino Substituted Fluorenones: These compounds exhibit the ability to inhibit protein kinase C, offering promising treatment options for neoplastic disease states, disorders related to abnormal blood flow, and inflammatory diseases.

2. 5-Acyl-2-(1H)Pyridinones: Novel cardiotonic agents with compounds like 5-acetyl-1,2-dihydro-6-methyl-2-oxo-3-pyridinecarbonitrile, showcasing Jones's diverse range of contributions to the pharmaceutical field.

Career Highlights:

Jones's career spanned across renowned pharmaceutical companies such as Merrell Dow Pharmaceuticals and Richardson-Merrell Inc., where he honed his skills and contributed significantly to the development of innovative pharmaceutical products.

Collaborations:

Throughout his career, Winton D Jones collaborated with esteemed professionals in the field, including Richard A Schnettler and Richard C Dage. These collaborations played a pivotal role in advancing his research and achieving groundbreaking results.

Conclusion:

In conclusion, Winton D Jones stands as a visionary inventor whose dedication to innovation has led to the creation of novel pharmaceutical compounds with the potential to transform the landscape of medical treatments. His relentless pursuit of excellence and collaborative spirit have solidified his position as a key figure in the realm of pharmaceutical inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…